New Alzheimer’s drug faces challenges
(By Alexandra Murphy for Becker’s Hospital Review ) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect
Read More(By Alexandra Murphy for Becker’s Hospital Review ) Leqembi, an Alzheimer’s drug from Biogen and Eisai, faces hurdles with respect
Read More(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read More(By Rylee Wilson for Becker’s Hospital Review ) Medicare Advantage beneficiaries are getting savvier and expecting more from their plans,
Read More(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read MoreDid you know Medicare has several different enrollment periods with separate rules for each? There is an Initial enrollment period,
Read More(By Mariah Taylor for Becker’s Hospital Review ) Pharmacy, cancer and musculoskeletal conditions remain the top drivers of increased healthcare
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More(By Paige Twenter for Becker’s Hospital Review ) About two-thirds of providers recently told Premier their teams are spending more
Read More(By Rylee Wilson for Becker’s Hospital Review ) Medicare spending could increase between $3.1 billion and $6.1 billion annually if
Read More(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read More